Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women

Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1092-7. doi: 10.1161/01.ATV.0000128410.23161.be. Epub 2004 Apr 15.

Abstract

Objective: To determine mechanisms contributing to decreased high-density lipoprotein cholesterol (HDL-C) and increased low-density lipoprotein cholesterol (LDL-C) concentrations associated with hydrogenated fat intake, kinetic studies of apoA-I, apoB-100, and apoB-48 were conducted using stable isotopes.

Methods and results: Eight postmenopausal hypercholesterolemic women were provided in random order with 3 diets for 5-week periods. Two-thirds of the fat was soybean oil (unsaturated fat), stick margarine (hydrogenated fat), or butter (saturated fat). Total and LDL-C levels were highest after the saturated diet (P<0.05; saturated versus unsaturated) whereas HDL-C levels were lowest after the hydrogenated diet (P<0.05; hydrogenated versus saturated). Plasma apoA-I levels and pool size (PS) were lower, whereas apoA-I fractional catabolic rate (FCR) was higher after the hydrogenated relative to the saturated diet (P<0.05). LDL apoB-100 levels and PS were significantly higher, whereas LDL apoB-100 FCR was lower with the saturated and hydrogenated relative to the unsaturated diet. There was no significant difference among diets in apoA-I or B-100 production rates or apoB-48 kinetic parameters. HDL-C concentrations were negatively associated with apoA-I FCR (r=-0.56, P=0.03) and LDL-C concentrations were negatively correlated with LDL apoB-100 FCR (r=-0.48, P=0.05).

Conclusions: The mechanism for the adverse lipoprotein profile observed with hydrogenated fat intake is determined in part by increased apoA-I and decreased LDL apoB-100 catabolism.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apolipoprotein A-I / blood*
  • Apolipoprotein B-100
  • Apolipoproteins B / blood*
  • Butter
  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood*
  • Cross-Over Studies
  • Dietary Fats / pharmacology*
  • Double-Blind Method
  • Female
  • Humans
  • Hypercholesterolemia / blood*
  • Kinetics
  • Margarine
  • Middle Aged
  • Postmenopause
  • Soybean Oil / pharmacology
  • Trans Fatty Acids / pharmacology*
  • Triglycerides / blood

Substances

  • Apolipoprotein A-I
  • Apolipoprotein B-100
  • Apolipoproteins B
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Dietary Fats
  • Trans Fatty Acids
  • Triglycerides
  • Soybean Oil
  • Butter
  • Margarine